Table 1.
Groups | n | Neurologic score | ||||
---|---|---|---|---|---|---|
Day 0 | Day 7 | Day 14 | Day 21 | Day 28 | ||
Sham | 6 | 0 ± 0 | 0 ± 0 | 0 ± 0 | 0 ± 0 | 0 ± 0 |
CIRU | 6 | 12.00* ± 0.58 | 11.33* ± 0.33 | 10.33* ± 0.33 | 9.33* ± 0.33 | 7.67* ± 0.67 |
Scu-50 | 6 | 12.67* ± 0.88 | 7.67*** ± 0.33 | 7.67*** ± 0.33 | 6.33*** ± 0.33 | 2.67*** ± 0.33 |
Scu-25 | 6 | 12.33* ± 0.33 | 9.67** ± 0.33 | 8.67** ± 0.33 | 7.33*** ± 0.33 | 5.67** ± 0.33 |
Nimodipine | 6 | 11.67* ± 0.33 | 10.33 ± 0.33 | 9.33 ± 0.33 | 7.67** ± 0.33 | 5.67** ± 0.33 |
Values are mean ± SD.
*P < 0.01; significantly higher compared with values of sham group.
**P < 0.05; significantly lower compared with values of CIRU group.
***P < 0.01; significantly lower compared with values of CIRU group.